Early Myocarditis Onset After Immunotherapy May Predict Treatment-related Fatality
SAN DIEGO – Patients who developed myocarditis within the first month of receiving immune checkpoint inhibitor therapy were more...
SAN DIEGO – Patients who developed myocarditis within the first month of receiving immune checkpoint inhibitor therapy were more...
The treatment preserved quality of life SAN DIEGO – Injecting nivolumab (Opdivo) directly into precancerous oral lesions led to...
SAN DIEGO – Exposure to wildfire smoke was associated with a significantly increased risk of lung, colorectal, breast, bladder,...
Keith T. Flaherty, MD, FAACR, begins term as AACR President SAN DIEGO – The members of the American Association...
PHILADELPHIA – The American Association for Cancer Research (AACR) is proud to announce its newest class of grant recipients. Since 1993, the AACR...
SAN DIEGO – Between 2020 and 2024, the number of unique sites in the United States where phase I clinical trials for non-small cell lung cancer (NSCLC) were conducted decreased by 44% and became increasingly...
All patients were negative for minimal residual disease, and no patients experienced progression to active multiple myeloma during the...
This approach may eventually help guide personalized treatment decisions for patients diagnosed with these cancers SAN DIEGO – A...
SAN DIEGO – A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response to...
AACR’s largest-ever grant program will award 15 early-stage and mid-career investigators with $1 million each over 3 years SAN...